Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Ritchie

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
The Cochrane Database of Systematic Reviews|March 23, 2017
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Craig Ritchie, Nadja Smailagic, Anna H Noel-Storr, et al.
Brain Communications|September 11, 2023
Genetic risks of Alzheimer's by <i>APOE</i> and <i>MAPT</i> on cortical morphology in young healthy adultsWeijie Huang, Jianmin Zeng, Lina Jia, et al.
The European Journal of Neuroscience|March 26, 2022
Associations between cerebrospinal fluid markers and cognition in ageing and dementia: A systematic reviewTyler S Saunders, Danni A Gadd, Tara L Spires-Jones, et al.
Journal of Medical Economics|January 28, 2026
Estimating the long-term health outcomes of treatment with lecanemab in early Alzheimer's disease: a modelling studyOliver Burn, Kate Molloy, Michio Kanekiyo, et al.
The Cochrane Database of Systematic Reviews|June 11, 2014
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Craig Ritchie, Nadja Smailagic, Anna H Noel-Storr, et al.
BMC Medical Research Methodology|January 29, 2011
Developing a Dementia Research Registry: a descriptive case study from North Thames DeNDRoN and the EVIDEM programmeSteve Iliffe, Lisa Curry, Kalpa Kharicha, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 27, 2020
Regional hyperperfusion in cognitively normal <i>APOE ε4</i> allele carriers in mid-life: analysis of ASL pilot data from the PREVENT-Dementia cohortElizabeth Frances McKiernan, Elijah Mak, Maria-Eleni Dounavi, et al.
Eye (London, England)|November 28, 2023
Multi-modal retinal imaging for investigating neurovascular healthSamuel Gibbon, Charlene Hamid, Adam Threlfall, et al.
Alzheimer'S Research & Therapy|April 20, 2022
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's diseaseSheila Seleri Assunção, Reisa A Sperling, Craig Ritchie, et al.
Journal of Neurology|June 26, 2023
Genetic risk factors of Alzheimer's Disease disrupt resting-state functional connectivity in cognitively intact young individualsLudmila Kucikova, Jianmin Zeng, Carlos Muñoz-Neira, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
The Cochrane Database of Systematic Reviews|March 23, 2017
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Craig Ritchie, Nadja Smailagic, Anna H Noel-Storr, et al.
Brain Communications|September 11, 2023
Genetic risks of Alzheimer's by <i>APOE</i> and <i>MAPT</i> on cortical morphology in young healthy adultsWeijie Huang, Jianmin Zeng, Lina Jia, et al.
The European Journal of Neuroscience|March 26, 2022
Associations between cerebrospinal fluid markers and cognition in ageing and dementia: A systematic reviewTyler S Saunders, Danni A Gadd, Tara L Spires-Jones, et al.
Journal of Medical Economics|January 28, 2026
Estimating the long-term health outcomes of treatment with lecanemab in early Alzheimer's disease: a modelling studyOliver Burn, Kate Molloy, Michio Kanekiyo, et al.
The Cochrane Database of Systematic Reviews|June 11, 2014
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Craig Ritchie, Nadja Smailagic, Anna H Noel-Storr, et al.
BMC Medical Research Methodology|January 29, 2011
Developing a Dementia Research Registry: a descriptive case study from North Thames DeNDRoN and the EVIDEM programmeSteve Iliffe, Lisa Curry, Kalpa Kharicha, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 27, 2020
Regional hyperperfusion in cognitively normal <i>APOE ε4</i> allele carriers in mid-life: analysis of ASL pilot data from the PREVENT-Dementia cohortElizabeth Frances McKiernan, Elijah Mak, Maria-Eleni Dounavi, et al.
Eye (London, England)|November 28, 2023
Multi-modal retinal imaging for investigating neurovascular healthSamuel Gibbon, Charlene Hamid, Adam Threlfall, et al.
Alzheimer'S Research & Therapy|April 20, 2022
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's diseaseSheila Seleri Assunção, Reisa A Sperling, Craig Ritchie, et al.
Journal of Neurology|June 26, 2023
Genetic risk factors of Alzheimer's Disease disrupt resting-state functional connectivity in cognitively intact young individualsLudmila Kucikova, Jianmin Zeng, Carlos Muñoz-Neira, et al.
Pageof 13